Patents Assigned to Constantia Gruppe
  • Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
    Patent number: 5912346
    Abstract: Methods and compositions for the prevention and/or inhibition of primary and secondary metastatic neoplasms are described. Individuals at a high risk of developing neoplasia and/or cancer patients undergoing conventional therapies may be treated with an effective dose of a salt of aminoimidazole carboxamide and/or of 5-amino or substituted amino 1,2,3-traizoles.
    Type: Grant
    Filed: November 10, 1997
    Date of Patent: June 15, 1999
    Assignee: Constantia Gruppe
    Inventor: Felix Wehrmann
  • Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
    Patent number: 5861406
    Abstract: Methods and compositions for the prevention and/or inhibition of primary and secondary metastatic neoplasms are described. Individuals at a high risk of developing neoplasia and/or cancer patients undergoing conventional therapies may be treated with an effective dose of a salt of aminoimidazole carboxamide and/or of 5-amino or substituted amino 1,2,3-traizoles.
    Type: Grant
    Filed: July 18, 1996
    Date of Patent: January 19, 1999
    Assignee: Constantia Gruppe
    Inventor: Felix Wehrmann
  • Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide
    Patent number: 5728707
    Abstract: Methods and compositions for the prevention and/or inhibition of primary and secondary metastatic neoplasms are described. Individuals at a high risk of developing neoplasia and/or cancer patients undergoing conventional therapies may be treated with an effective dose of a salt of aminoimidazole carboxamide.
    Type: Grant
    Filed: July 21, 1995
    Date of Patent: March 17, 1998
    Assignee: Constantia Gruppe
    Inventor: Felix Wehrmann